Am J Kidney Dis

1. MORTON JI, Carstensen B, McDonald SP, Polkinghorne KR, et al
   Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
   Am J Kidney Dis. 2023;82:608-616.
   

   >> Share

   
   
2. REILY C, Novak J, Rizk DV
   The Roles of A Proliferation-Inducing Ligand (APRIL) and B-Cell Activating Factor (BAFF) in IgA Nephropathy.
   Am J Kidney Dis. 2026 Mar 5:S0272-6386(26)00729.
   

   >> Share

   
   

   
   BMC Neurol

3. MACHADO A, Dervish J, Friberg E
   Employment status and self-rated health in people with multiple sclerosis in Sweden.
   BMC Neurol. 2026 Mar 11. doi: 10.1186/s12883-026-04809.
   

   >> Share

   
   
4. KIMBER C, Malouf R, Javan J, Doree C, et al
   Clinical and economic outcomes of therapeutic plasma exchange and intravenous immunoglobulin for treating adults with autoimmune neurological disorders: a systematic review and meta-analysis.
   BMC Neurol. 2026 Mar 7. doi: 10.1186/s12883-026-04780.
   

   >> Share

   
   
5. SHU J, Zhou Y, Xu Z, Wei W, et al
   MELAS syndrome complicated by anti-GFAP autoantibody positivity: a case report and literature review.
   BMC Neurol. 2026 Mar 7. doi: 10.1186/s12883-026-04745.
   

   >> Share

   
   

   
   Brain

6. CORAZZOLLA G, Treaba CA, Mohammadian M, Brusaferri L, et al
   Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression.
   Brain. 2026 Mar 9:awag084. doi: 10.1093.
   

   >> Share

   
   
7. PAUL F
   Beyond autoantibodies: accelerating differential diagnosis in neuroimmunological diseases.
   Brain. 2026 Mar 11:awag093. doi: 10.1093.
   

   >> Share

   
   
8. YOGESHWAR SM, Bartels F, Gruter T, Muniz-Castrillo S, et al
   Brain atrophy patterns in anti-IgLON5 disease.
   Brain. 2026;149:884-896.
   

   >> Share

   
   

   
   Curr Opin Immunol

9. GROSSI C, Buckle II, McDonnell TC
   Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?
   Curr Opin Immunol. 2026;100:102748.
   

   >> Share

   
   
10. KIRINO Y, Takeno M
    A critical look at animal and cellular models in autoinflammatory diseases.
    Curr Opin Immunol. 2026;99:102719.
    

    >> Share

    
    

    
    Diabet Med

11. MANSBRIDGE SE, Kozlowska O, Lumb A, Rea R, et al
    A multi-centre qualitative study of experiences of managing diabetes mellitus among adults while hospitalised.
    Diabet Med. 2026 Feb 18:e70256. doi: 10.1111/dme.70256.
    

    >> Share

    
    
12. SANCHEZ-GARCIA D, Luna-Garza Y, Saavedra-Castillo E, Gomez-Martinez G, et al
    Effect of liraglutide on subclinical atherosclerosis and cardiometabolic risk factors in adults with type 1 diabetes: A prospective pilot study.
    Diabet Med. 2026 Feb 15:e70222. doi: 10.1111/dme.70222.
    

    >> Share

    
    
13. SHACHAM EC, Sharif S, Tatoor R, Ayalon S, et al
    Prevalence and outcomes of DKA in type 1 and type 2 DM patients treated and not treated with SGLT-2 inhibitors.
    Diabet Med. 2026;43:e70237.
    

    >> Share

    
    
14. HAGGER V, Hendrieckx C, Cotterill A, Speight J, et al
    Evaluation of a structured type 1 diabetes education program for adolescents and parents: Teens Empowered to Actively Manage Type 1 (TEAM T1).
    Diabet Med. 2026 Feb 5:e70244. doi: 10.1111/dme.70244.
    

    >> Share

    
    
15. COOPER ZW, Davis GM, Pasquel FJ, Johnson LCM, et al
    Navigating the dual burden of type 1 diabetes and mental illness: A phenomenological study.
    Diabet Med. 2026 Feb 5:e70200. doi: 10.1111/dme.70200.
    

    >> Share

    
    
16. SOHOLM U, Holmes-Truscott E, Amiel SA, de Galan B, et al
    Assessing thoughts, feelings and behaviours related to hypoglycaemia: Psychometric evaluation of the Hypoglycaemia Cues Questionnaire (HypoC-Q).
    Diabet Med. 2026;43:e70231.
    

    >> Share

    
    
17. MECANI R, Muka T, Cigler M, Basta S, et al
    The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations.
    Diabet Med. 2026 Jan 23:e70220. doi: 10.1111/dme.70220.
    

    >> Share

    
    
18. ZIEGLER J, Neu A, Ehehalt S, Schweizer R, et al
    Age-specific incidence and prevalence of childhood type 1 diabetes: Development over four decades in Southwest Germany.
    Diabet Med. 2026 Jan 6:e70215. doi: 10.1111/dme.70215.
    

    >> Share

    
    

    
    Diabetes

19. THIRAWATANANOND P, Brown ME, Sachs LK, Arnoletti JM, et al
    Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability.
    Diabetes. 2023;72:1629-1640.
    

    >> Share

    
    

    
    Diabetes Res Clin Pract

20. MARLOW AL, King BR, Trost SG, Weaver N, et al
    Healthy weight and overweight adolescents with type 1 diabetes mellitus do not meet recommendations for daily physical activity and sleep.
    Diabetes Res Clin Pract. 2023;203:110879.
    

    >> Share

    
    
21. JENKINS AJ, Carroll LM, Huang MLH, Wen-Loh Y, et al
    Mitochondrial DNA copy number in adults with and without Type 1 diabetes.
    Diabetes Res Clin Pract. 2023;203:110877.
    

    >> Share

    
    
22. WANNES S, Gamal GM, Fredj MB, Al Qusayer D, et al
    Glucose control during Ramadan in a pediatric cohort with type 1 diabetes on MiniMed standard and advanced hybrid closed?loop systems: A pilot study.
    Diabetes Res Clin Pract. 2023;203:110867.
    

    >> Share

    
    
23. SAJJADI SF, Sacre JW, Chen L, Wild SH, et al
    Algorithms to define diabetes type using data from administrative databases: A systematic review of the evidence.
    Diabetes Res Clin Pract. 2023;203:110859.
    

    >> Share

    
    
24. POLICOLA C, Di Stasio E, Rizzi A, Foca F, et al
    Predisposition to eating disorders in adults with type 1 diabetes: Comparison between multiple daily injections and continuous subcutaneous insulin infusion.
    Diabetes Res Clin Pract. 2023;203:110882.
    

    >> Share

    
    
25. WINTERDIJK P, Aanstoot HJ, Nefs G
    The impact of real-time sensor technology on quality of life for adults with type 1 diabetes: A Dutch national survey.
    Diabetes Res Clin Pract. 2023;203:110886.
    

    >> Share

    
    
26. SEATON KM, Jones HC, Lee MH, Kilov G, et al
    Survey of glucose levels in adults with T1DM attending clinic using automated insulin delivery (AID) devices compared with manual insulin delivery.
    Diabetes Res Clin Pract. 2026;233:113136.
    

    >> Share

    
    
27. QU HQ, Ostberg K, Slater DJ, Wang F, et al
    Sex specific genomic insights into type 1 diabetes through GWAS and single cell transcriptome analysis.
    Diabetes Res Clin Pract. 2026;234:113181.
    

    >> Share

    
    
28. HEAGUE MO, Henney AE, Riley DR, Anson M, et al
    Long-term adverse multi-system health outcomes of gestational diabetes mellitus: an analysis of real-world cohort data.
    Diabetes Res Clin Pract. 2026;234:113171.
    

    >> Share

    
    

    
    Intern Med

29. SAKURAI K, Ashikawa Y, Imaoka Y, Ohshima K, et al
    Adult T-cell Leukemia Following Satralizumab Treatment for Neuromyelitis Optica Spectrum Disorder.
    Intern Med. 2026;65:732-736.
    

    >> Share

    
    
30. KUWAHARA Y, Nanri M, Kurihara Y, Tashiro H, et al
    Pulmonary Involvement in ANCA-associated Vasculitis Overlapping with Long-standing Systemic Lupus Erythematosus.
    Intern Med. 2026 Mar 10. doi: 10.2169/internalmedicine.6896.
    

    >> Share

    
    

    
    J Immunol

31. CHEN J, Fu L, Gong Y, Liao L, et al
    IFNgamma/JAK/STAT1/CD38 pathway in SH2D1Bhigh NK cells: Implications for inflammation in type 1 diabetes.
    J Immunol. 2026;215:vkaf347.
    

    >> Share

    
    

    
    J Nephrol

32. HUANG J, Xiao T, Zhang J, Li Y, et al
    Ambrisentan as adjunctive therapy for IgA nephropathy: a retrospective single-center analysis.
    J Nephrol. 2026 Feb 27:aajaf052. doi: 10.1093.
    

    >> Share

    
    

    
    J Neuroimmunol

33. BENKHOUCHA M, Breville G, Senoner I, Chliate S, et al
    Soluble c-Met correlates with NfL and GFAP levels in the CSF of patients with multiple sclerosis.
    J Neuroimmunol. 2026;415:578895.
    

    >> Share

    
    
34. DAMSBO K, Reyahi A, Nik AM, Oubounyt M, et al
    Astrocyte-specific FoxF2 modulates immune and myelin repair: Evidence from multiple sclerosis lesions and an animal model.
    J Neuroimmunol. 2026;415:578896.
    

    >> Share

    
    
35. ATASEVER U
    Bile acid-microbiota interactions in multiple sclerosis: From experimental models to early clinical evidence.
    J Neuroimmunol. 2026;415:578898.
    

    >> Share

    
    
36. SARIN S, Modak N, Sun R, Subei O, et al
    Predicting the final clinical phenotype after the first attack of optic neuritis.
    J Neuroimmunol. 2023;381:578130.
    

    >> Share

    
    
37. BLASK C, Schulze J, Rumpel S, Susse M, et al
    Modulation of cytokine release from peripheral blood mononuclear cells from multiple sclerosis patients by coenzyme A and soraphen A.
    J Neuroimmunol. 2023;381:578135.
    

    >> Share

    
    
38. SANDWEISS AJ, Erickson TA, Jiang Y, Kannan V, et al
    Infectious profiles in pediatric anti-N-methyl-d-aspartate receptor encephalitis.
    J Neuroimmunol. 2023;381:578139.
    

    >> Share

    
    
39. JAIN K, Anita M, Netravathi M
    Double hit - A case in point for dual seropositivity to AQP4 and MOG antibodies.
    J Neuroimmunol. 2023;383:578198.
    

    >> Share

    
    
40. EVERS SMITH C, Scholz A, Zolno R, Gambrah-Lyles C, et al
    Safety and efficacy of intrathecal rituximab in refractory neuroimmune disorders- a case series.
    J Neuroimmunol. 2026;414:578890.
    

    >> Share

    
    

    
    J Neurol

41. PETROU P, Achiron A, Cohen EG, Garty M, et al
    Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group‏ Viewpoint.
    J Neurol. 2023 Jul 12. doi: 10.1007/s00415-023-11846.
    

    >> Share

    
    
42. QIN M, Chen J, Guo X, Xiang X, et al
    Movement disorders in autoimmune encephalitis: an update.
    J Neurol. 2023;270:5288-5302.
    

    >> Share

    
    
43. JAKIMOVSKI D, Zivadinov R, Weinstock Z, Fuchs TA, et al
    Cortical thickness and cognition in older people with multiple sclerosis.
    J Neurol. 2023 Aug 27. doi: 10.1007/s00415-023-11945.
    

    >> Share

    
    
44. BONACCHI R, Valsasina P, Pagani E, Meani A, et al
    Sex-related differences in upper limb motor function in healthy subjects and multiple sclerosis patients: a multiparametric MRI study.
    J Neurol. 2023 Aug 28. doi: 10.1007/s00415-023-11948.
    

    >> Share

    
    
45. GENG C, Zhao W, Wang Z, Wu J, et al
    Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review.
    J Neurol. 2023;270:5171-5181.
    

    >> Share

    
    
46. OEZTUERK M, Huntemann N, Gerischer L, Herdick M, et al
    Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study.
    J Neurol. 2026;273:168.
    

    >> Share

    
    
47. BERGAMASCHI R, Ferraro OE, Enrico P, Marzia F, et al
    Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.
    J Neurol. 2026;273:172.
    

    >> Share

    
    
48. RICE C, Scolding N
    Primary central nervous system vasculitis: an update.
    J Neurol. 2026;273:179.
    

    >> Share

    
    
49. KLOSTERMANN F, Steiner OL
    Non-sensorimotor symptoms in chronic inflammatory demyelinating polyneuropathy.
    J Neurol. 2026;273:178.
    

    >> Share

    
    
50. KLEIN KRANENBARG RAM, Blok KM, van Hasselt Y, Melisse S, et al
    Symptoms of depression and anxiety are early predictors of multi-domain disability progression in progressive MS.
    J Neurol. 2026;273:182.
    

    >> Share

    
    
51. MIEGEL L, Hickstein J, Reibelt A, Heesen C, et al
    Myasthenia gravis and pregnancy: a systematic review and meta-analysis.
    J Neurol. 2026;273:184.
    

    >> Share

    
    
52. MOLENAAR PCG, de Jong DJ, Hof SN, van Oirschot P, et al
    Digital monitoring of disease activity in relapsing-remitting multiple sclerosis.
    J Neurol. 2026;273:186.
    

    >> Share

    
    
53. FREEDMAN DE, Benedict RHB, Oh J, Feinstein A, et al
    The non-linear relationship between self-reported cognitive concerns and performance-based cognitive dysfunction in people with multiple sclerosis: a cross-sectional study.
    J Neurol. 2026;273:190.
    

    >> Share

    
    
54. CANDELORO R, Laudisi M, Ferri C, Baldi E, et al
    Beyond oligoclonal bands: the independent role of kappa free light chains in the diagnostic workup of multiple sclerosis.
    J Neurol. 2026;273:191.
    

    >> Share

    
    
55. DIMITRIADOU EM, Tzanetakos D, Theodorou A, Akrivaki A, et al
    The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naive patients with multiple sclerosis.
    J Neurol. 2026;273:194.
    

    >> Share

    
    
56. GUERRA T, Lucisano G, Rocca MA, Cocco E, et al
    HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.
    J Neurol. 2026;273:193.
    

    >> Share

    
    

    
    J Pediatr Endocrinol Metab

57. MAINIERI F, Chiarelli F, Betterle C, Bernasconi S, et al
    Graves' disease after COVID mRNA vaccination for the first time diagnosed in adolescence-case report. Cause and effect relationship or simple coincidence?
    J Pediatr Endocrinol Metab. 2023;36:993-997.
    

    >> Share

    
    
58. MUTLUER T, Aslan Genc H, Demir T, Demirel C, et al
    The effect of problem-solving skills on blood glucose regulation and disease management in children with type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2023;36:949-956.
    

    >> Share

    
    
59. ODEH R, Gharaibeh L, Ibrahim S, Alassaf A, et al
    Associated autoimmune thyroid diseases in children and adolescents with type one diabetes in Jordan.
    J Pediatr Endocrinol Metab. 2023;36:917-924.
    

    >> Share

    
    
60. ELHENAWY YI, Shaarawy MA, Selim EM
    Safety and efficacy of the structured onboarding steps and initiation protocol for MiniMed 780G system among an Egyptian cohort of young people living with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2023;36:941-948.
    

    >> Share

    
    
61. KARA A, Gercek HG, Ozkan Y, Celikkol Sadic C, et al
    Depression, anxiety, eating problems, and diabulimia risk in adolescents with type 1 diabetes: a case-control study.
    J Pediatr Endocrinol Metab. 2023;36:957-965.
    

    >> Share

    
    
62. KOPRULU O, Karatas MC, Akbel S, Simsek FY, et al
    Impact of continuous glucose monitoring on fear of hypoglycemia and quality of life in children and adolescents with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2026;39:258-264.
    

    >> Share

    
    
63. POON SW, Chan KT, But BW, Wong SM, et al
    Suboptimal adoption of diabetes technology despite coverage and the impact on glycemic outcomes in children and adolescents with type 1 diabetes in Hong Kong.
    J Pediatr Endocrinol Metab. 2026;39:251-257.
    

    >> Share

    
    

    
    J Rheumatol

64. CONCANNON HR, Sun K, Rogers JL, Clowse MEB, et al
    Differences in Self-Reported Medication Nonadherence and its Drivers in Young Adults versus Older Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Mar 1:jrheum.2025-0602. doi: 10.3899/jrheum.2025-0602.
    

    >> Share

    
    

    
    Kidney Int

65. AL JURDI A, Kotton CN, Lafayette R
    Modern challenges in infection prevention: encapsulated organisms in the era of novel complement inhibitors.
    Kidney Int. 2026;109:484-488.
    

    >> Share

    
    
66. LEE M, Suzuki H, Ogiwara K, Aoki R, et al
    The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy.
    Kidney Int. 2023;104:943-955.
    

    >> Share

    
    

    
    Mult Scler

67. SPAGNOLO F, Gordaliza PM, Bhardwaj A, Lu PJ, et al
    A multi-modal deep learning network for the classification of paramagnetic rim and remyelinated lesions in multiple sclerosis.
    Mult Scler. 2026 Mar 6:13524585261421491. doi: 10.1177/13524585261421491.
    

    >> Share

    
    
68. CORONA A, Clarelli F, Paakkonen K, Harroud A, et al
    Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.
    Mult Scler. 2026 Mar 3:13524585261417130. doi: 10.1177/13524585261417130.
    

    >> Share

    
    
69. ABAD-INCHAURRONDO I, Lu S, Lui E, Susin-Calle S, et al
    Performance of the 2024 McDonald diagnostic criteria for multiple sclerosis.
    Mult Scler. 2026 Mar 3:13524585261421816. doi: 10.1177/13524585261421816.
    

    >> Share

    
    
70. SIVA A, Kantarci O
    Multiple sclerosis controversies: Do MRI-negative relapses really exist? - Commentary.
    Mult Scler. 2026 Mar 3:13524585261423082. doi: 10.1177/13524585261423082.
    

    >> Share

    
    
71. EBRAHIMI A, Wiil UK, Olsson T, Lio P, et al
    A susceptibility network analysis of disease trajectories leading to multiple sclerosis: A nationwide cohort study.
    Mult Scler. 2026 Mar 10:13524585261421480. doi: 10.1177/13524585261421480.
    

    >> Share

    
    
72. NOVA A, Di Caprio G, Gentilini D, Bernardinelli L, et al
    A bidirectional two-sample Mendelian randomization study of immune responses against Epstein-Barr virus nuclear antigen 1 and multiple sclerosis in individuals of European ancestry.
    Mult Scler. 2026 Mar 10:13524585261423063. doi: 10.1177/13524585261423063.
    

    >> Share

    
    
73. INOJOSA H, Mathias R, Dillenseger A, Voigt I, et al
    AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research.
    Mult Scler. 2026 Mar 13:13524585261424136. doi: 10.1177/13524585261424136.
    

    >> Share

    
    
74. GRECO G, Delgado S, Francis A, Miron M, et al
    Predictive factors for immunosuppression-associated severe and opportunistic infections in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.
    Mult Scler. 2026;32:326-337.
    

    >> Share

    
    
75. WENGER AL, Pagani E, Meani A, Preziosa P, et al
    Clinical and MRI substrates of Symbol Digit Modalities Test impairment in multiple sclerosis patients with an adult- and late-onset.
    Mult Scler. 2026 Feb 23:13524585261417265. doi: 10.1177/13524585261417265.
    

    >> Share

    
    
76. FUJIHARA K, Isobe N, Miyamoto K, Niino M, et al
    Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).
    Mult Scler. 2026;32:302-314.
    

    >> Share

    
    

    
    N Engl J Med

77. HEERSPINK HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, et al
    Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2026;394:947-957.
    

    >> Share

    
    
78. FURIE RA, Dall'Era M, Vital EM, Garg JP, et al
    Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.
    N Engl J Med. 2026 Mar 6. doi: 10.1056/NEJMoa2516150.
    

    >> Share

    
    

    
    Nat Rev Neurol

79. GRIMSEY B
    We need to talk about risk in multiple sclerosis.
    Nat Rev Neurol. 2026;22:137.
    

    >> Share

    
    

    
    Neurol Clin Pract

80. BOVE R, Simoni M, Castelo-Branco C, Correale J, et al
    Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program.
    Neurol Clin Pract. 2026;16:e200588.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

81. NAG A, Leon-Ruiz M, Bole K, Ghosh R, et al
    Alcoholic Wernicke's encephalopathy with cranial neuropathies, atypical neuroimaging, dry beriberi, and Graves' disease: A novel variant?
    Neurologia (Engl Ed). 2026;41:101892.
    

    >> Share

    
    
82. GHOSH R, Leon-Ruiz M, Bole K, Dubey S, et al
    Isolated bilateral facial palsy as the initial presenting manifestation of generalized myasthenia gravis preceding myasthenic crisis.
    Neurologia (Engl Ed). 2026;41:101894.
    

    >> Share

    
    

    
    Neurology

83. MARTINEZ SOSA S, Tisavipat N, Betting T, Guo Y, et al
    Pearls & Oy-sters: Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis.
    Neurology. 2026;106:e214794.
    

    >> Share

    
    
84. SIRIRATNAM P, Jokubaitis VG, Van Der Walt A, Sanfilippo PG, et al
    Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2026;106:e214707.
    

    >> Share

    
    
85. JACOBS BM, Schalk L, Tregaskis-Daniels E, Scalfari A, et al
    Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.
    Neurology. 2026;106:e214708.
    

    >> Share

    
    
86. KIM SH, Lee EJ, Lim YM, Kim H, et al
    Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.
    Neurology. 2026;106:e214792.
    

    >> Share

    
    

    
    PLoS Biol

87. JOHNSTONE JC, Mitchell R, Vyse TJ, Clarke AJ, et al
    The adaptor protein TASL is required for age-related B cell emergence and lupus-like disease development in mice.
    PLoS Biol. 2026;24:e3003342.
    

    >> Share

    
    

    
    PLoS One

88. TAUFIQQURRACHMAN I, Witarto AP, Syam AF, Abdullah M, et al
    Diagnostic potential of total serum ghrelin in autoimmune gastritis: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0344129.
    

    >> Share

    
    
89. GIORDANO A, De Panfilis L, Zagarella RM, Di Domenico G, et al
    Communication competences of multiple sclerosis neurologists during advance care planning conversations: A multi-observer study.
    PLoS One. 2026;21:e0336183.
    

    >> Share

    
    
90. LIANG C, Zhuo P, Zhang Y
    Leukotriene receptor antagonists and eosinophilic granulomatosis with polyangiitis: a disproportionality analysis from FAERS, JADER, CVAR databases integrated with network pharmacology.
    PLoS One. 2026;21:e0343084.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

91. LUM FM, Sattarnezhad N, Ho PP, Orr N, et al
    Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2026;123:e2519445123.
    

    >> Share

    
    
92. JANOVICOVA L, Janikova M, Pastorek M, Csizmadia E, et al
    Extracellular heme:DNA complexes promote oxidative stress and inflammation during lupus-associated hemolysis.
    Proc Natl Acad Sci U S A. 2026;123:e2526577123.
    

    >> Share

    
    

    
    Thyroid

93. HAMADI D, Saad-Omer S, Toro-Tobon D, Stan MN, et al
    Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?
    Thyroid. 2026;36:213-218.
    

    >> Share

    
    
94. KAHALY GJ, Wolf J, Luffy M, Albert K, et al
    Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case Report.
    Thyroid. 2026 Feb 13:10507256261423190. doi: 10.1177/10507256261423190.
    

    >> Share

    
    
95. TORO-TOBON D, Rachmasari K, Bradley E, Wagner L, et al
    Medical Therapy in Patients with Moderate to Severe, Steroid-resistant, Thyroid Eye Disease.
    Thyroid. 2023 Jul 29. doi: 10.1089/thy.2023.0167.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share